Nevin Varghese
Analyst
RBC Capital Markets
Equibles does not estimate personal net worth.
About Nevin Varghese
Nevin Varghese is recorded as Analyst at RBC Capital Markets. Nevin Varghese has spoken on 4 investor events across 4 companies, most recently for Vistagen Therapeutics, Inc. on May 20, 2026. Those appearances were for Vistagen Therapeutics, Inc. (VTGN), DiaMedica Therapeutics Inc. (DMAC), Acadia Pharmaceuticals Inc (ACAD) and Contineum Therapeutics, Inc. (CTNM). The companies whose calls Nevin Varghese spoke on are classified in the Healthcare sector.
Nevin Varghese on recent calls
“I'm one of the biotech analysts here at RBC Capital Markets, and I'm joined on stage by the CEO of Vistagen Therapeutics, Sean Singh. Sean, thank you so much for joining us.”
“I'm with RBC Capital Markets, one of the analysts here. And I'm joined on stage by Rick Pauls, who is the CEO of Diamedica Therapeutics. Rick, thank you for joining us today.”
“I'm here joined by Acadia Pharmaceuticals, Mark Scheiner, Tom Gardner, and Sanjeev Fatik. And yeah, get right into it. So I know a lot of these conversations usually start out with looking at the commercial trajectory of New Closet and Debut, and I promise we'll get to that as well.”
“I'm one of the analysts at RBC Capital Markets. Thank you for joining us today. We have with us Carmine Stengon, who's the president and CEO of Continuum Therapeutics.”
Affiliation history
-
RBC Capital Markets
Analyst
Transcript header (unverified)
Current